Clinical Study of Guizhi Fuling Pills in the Treatment of Uterine Fibroids
Objective:To explore the clinical effect and safety of Guizhi Fuling Pills in the treatment of uterine fibroids.Method:A total of 80 patients with uterine fibroids who admitted to Quanzhou Quangang District Hospital from February 2022 to August 2023 were selected as the study objects,the patients were divided into the control group and the observation group by random number table method,40 cases in each group.The control group was treated with Mifepristone,and the observation group was treated with Guizhi Fuling Pills on the basis of the control group.The sex hormone levels,blood viscosity,uterine fibroids volume and adverse reactions were compared between two groups.Result:After treatment,the levels of follicle stimulating hormone,estradiol,progesterone,whole blood viscosity and plasma viscosity in two groups were lower than those before treatment,and those in the observation group were lower than the control group,the differences were statistically significant(P<0.05);after treatment,the uterine fibroids volume in two groups were smaller than those before treatment,and that in the observation group was smaller than that in the control group,the differences were statistically significant(P<0.05);there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Guizhi Fuling Pills in the treatment of uterine fibroids can effectively improve the level of sex hormones and blood viscosity,reduce the uterine fibroids volume,and has high safety.
万方数据
维普
